Evidence map›Paper›PMID 30543681›Full record

ArticlePLoS genetics2018

Biallelic mutations in nucleoporin NUP88 cause lethal fetal akinesia deformation sequence.

Edith Bonnin, Pauline Cabochette, Alessandro Filosa, Ramona Jühlen, Shoko Komatsuzaki, Mohammed Hezwani, Achim Dickmanns, Valérie Martinelli, Marjorie Vermeersch, Lynn Supply and 16 more

Abstract readCase Reports
In one paragraph

Article in PLoS genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Journal of obstetrics and gynaecology of India · 2025
    Article
  5. Review
  6. Article
  7. Advances in the understanding of nuclear pore complexes in human diseases.Journal of cancer research and clinical oncology · 2024
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Structure and Function of the Nuclear Pore Complex.Cold Spring Harbor perspectives in biology · 2022
    Review
  13. Nuclear Pore Dysfunction in Neurodegeneration.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2022
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Edith BonninInstitute of Molecular Biology and Medicine, Laboratory Biology of the Cell Nucleus, Université Libre de Bruxelles (ULB), Gosselies, Belgium.
Pauline CabochetteLaboratory of Neurovascular Signaling, Department of Molecular Biology, ULB Neuroscience Institute, Université Libre de Bruxelles (ULB), Gosselies, Belgium.
Alessandro FilosaMax Delbrück Center for Molecular Medicine, Berlin, Germany.ORCID 0000-0003-2599-6951
Ramona JühlenInstitute of Molecular Biology and Medicine, Laboratory Biology of the Cell Nucleus, Université Libre de Bruxelles (ULB), Gosselies, Belgium.ORCID 0000-0002-5689-9030
Shoko KomatsuzakiInstitute of Human Genetics, Martin-Luther-University Halle-Wittenberg, Halle, Germany.
Mohammed HezwaniInstitute of Molecular Biology and Medicine, Laboratory Biology of the Cell Nucleus, Université Libre de Bruxelles (ULB), Gosselies, Belgium.
Achim DickmannsDepartment of Molecular Structural Biology, Institute for Microbiology and Genetics, GZMB, Georg-August-University Göttingen, Göttingen, Germany.
Valérie MartinelliInstitute of Molecular Biology and Medicine, Laboratory Biology of the Cell Nucleus, Université Libre de Bruxelles (ULB), Gosselies, Belgium.
Marjorie VermeerschCenter for Microscopy and Molecular Imaging, Université Libre de Bruxelles, Charleroi, Belgium.
Lynn SupplyDepartment of Pathology, Ghent University, Ghent University Hospital, Ghent, Belgium.
Nuno MartinsInstitute of Molecular Biology and Medicine, Laboratory Biology of the Cell Nucleus, Université Libre de Bruxelles (ULB), Gosselies, Belgium.ORCID 0000-0002-8797-2843
Laurence PirenneInstitute of Molecular Biology and Medicine, Laboratory Biology of the Cell Nucleus, Université Libre de Bruxelles (ULB), Gosselies, Belgium.ORCID 0000-0003-4238-8501
Gianina RavenscroftHarry Perkins Institute of Medical Research, Centre for Medical Research, University of Western Australia, Nedlands, Western Australia, Australia.ORCID 0000-0003-3634-211X
Marcus LombardHarry Perkins Institute of Medical Research, Centre for Medical Research, University of Western Australia, Nedlands, Western Australia, Australia.
Sarah PortDepartment of Molecular Biology, Faculty of Medicine, Georg-August-University of Göttingen, Göttingen, Germany.ORCID 0000-0002-1897-0510
Christiane SpillnerDepartment of Molecular Biology, Faculty of Medicine, Georg-August-University of Göttingen, Göttingen, Germany.
Sandra JanssensCenter for Medical Genetics, Ghent University Hospital, Ghent, Belgium.ORCID 0000-0001-7262-3715
Ellen RoetsDepartment of Obstetrics and Gynecology, Prenatal Diagnosis Centre, Ghent University Hospital, Ghent, Belgium.ORCID 0000-0003-2315-614X
Jo Van DorpeDepartment of Pathology, Ghent University, Ghent University Hospital, Ghent, Belgium.ORCID 0000-0002-0783-4484
Martin LammensDepartment of Pathology, Antwerp University Hospital, Egdem, Belgium.
Ralph H KehlenbachDepartment of Molecular Biology, Faculty of Medicine, Georg-August-University of Göttingen, Göttingen, Germany.
Ralf FicnerDepartment of Molecular Structural Biology, Institute for Microbiology and Genetics, GZMB, Georg-August-University Göttingen, Göttingen, Germany.ORCID 0000-0002-1739-6086
Nigel G LaingHarry Perkins Institute of Medical Research, Centre for Medical Research, University of Western Australia, Nedlands, Western Australia, Australia.ORCID 0000-0001-5111-3732
Katrin HoffmannInstitute of Human Genetics, Martin-Luther-University Halle-Wittenberg, Halle, Germany.
Benoit VanhollebekeLaboratory of Neurovascular Signaling, Department of Molecular Biology, ULB Neuroscience Institute, Université Libre de Bruxelles (ULB), Gosselies, Belgium.ORCID 0000-0002-0353-365X
Birthe FahrenkrogInstitute of Molecular Biology and Medicine, Laboratory Biology of the Cell Nucleus, Université Libre de Bruxelles (ULB), Gosselies, Belgium.ORCID 0000-0003-4080-9413

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nucleoporins build the nuclear pore complex (NPC), which, as sole gate for nuclear-cytoplasmic exchange, is of outmost importance for normal cell function. Defects in the process of nucleocytoplasmic transport or in its machinery have been frequently described in human diseases, such as cancer and neurodegenerative disorders, but only in a few cases of developmental disorders. Here we report biallelic mutations in the nucleoporin NUP88 as a novel cause of lethal fetal akinesia deformation sequence (FADS) in two families. FADS comprises a spectrum of clinically and genetically heterogeneous disorders with congenital malformations related to impaired fetal movement. We show that genetic disruption of nup88 in zebrafish results in pleiotropic developmental defects reminiscent of those seen in affected human fetuses, including locomotor defects as well as defects at neuromuscular junctions. Phenotypic alterations become visible at distinct developmental stages, both in affected human fetuses and in zebrafish, whereas early stages of development are apparently normal. The zebrafish phenotypes caused by nup88 deficiency are rescued by expressing wild-type Nup88 but not the disease-linked mutant forms of Nup88. Furthermore, using human and mouse cell lines as well as immunohistochemistry on fetal muscle tissue, we demonstrate that NUP88 depletion affects rapsyn, a key regulator of the muscle nicotinic acetylcholine receptor at the neuromuscular junction. Together, our studies provide the first characterization of NUP88 in vertebrate development, expand our understanding of the molecular events causing FADS, and suggest that variants in NUP88 should be investigated in cases of FADS.

Indexed as

Genes, LethalMutationAllelesAmino Acid SequenceAnimalsAnimals, Genetically ModifiedArthrogryposisConsanguinityDisease Models, AnimalFemaleHumansMaleMiceModels, MolecularMuscle ProteinsNeuromuscular JunctionMuscle ProteinsNuclear Pore Complex ProteinsNUP88 protein, humanperipheral membrane protein 43KReceptors, NicotinicZebrafish Proteins

Identifiers

PMID30543681
PMCPMC6307818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.